111 related articles for article (PubMed ID: 12586814)
1. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?
Masci G; Magagnoli M; Zucali PA; Castagna L; Carnaghi C; Sarina B; Pedicini V; Fallini M; Santoro A
J Clin Oncol; 2003 Feb; 21(4):736-9. PubMed ID: 12586814
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients.
Magagnoli M; Masci G; Castagna L; Zucali PA; Morenghi E; Pedicini V; Santoro A
Anticancer Res; 2005; 25(4):3143-7. PubMed ID: 16080578
[TBL] [Abstract][Full Text] [Related]
3. Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?
Magagnoli M; Castagna L; Masci G; Santoro A
Oncologist; 2004; 9(5):594-5; author reply 596. PubMed ID: 15477645
[No Abstract] [Full Text] [Related]
4. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.
Magagnoli M; Masci G; Castagna L; Pedicini V; Poretti D; Morenghi E; Brambilla G; Santoro A
Am J Hematol; 2006 Jan; 81(1):1-4. PubMed ID: 16369969
[TBL] [Abstract][Full Text] [Related]
5. An adverse interaction between warfarin and 5-fluorouracil: A case report and review of the literature.
Brown MC
Chemotherapy; 1999; 45(5):392-5. PubMed ID: 10473927
[TBL] [Abstract][Full Text] [Related]
6. High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimens.
Magagnoli M; Masci G; Castagna L; Morenghi E; Santoro A
Ann Oncol; 2006 Jan; 17(1):174-6. PubMed ID: 16100233
[No Abstract] [Full Text] [Related]
7. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis.
Heaton DC; Han DY; Inder A
Intern Med J; 2002 Mar; 32(3):84-8. PubMed ID: 11885848
[TBL] [Abstract][Full Text] [Related]
8. An adverse interaction between warfarin and fluoropyrimidines revisited.
Saif MW
Clin Colorectal Cancer; 2005 Sep; 5(3):175-80. PubMed ID: 16197620
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
10. Warfarin-5-FU interactions.
Giunta G
Ann Oncol; 2006 Jan; 17(1):176. PubMed ID: 16126735
[No Abstract] [Full Text] [Related]
11. A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
Shah HR; Ledbetter L; Diasio R; Saif MW
Clin Colorectal Cancer; 2006 Jan; 5(5):354-8. PubMed ID: 16512995
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.
Shah SR; Martin R; Dowell JE; Ussery SM
Pharmacotherapy; 2010 Dec; 30(12):1259-65. PubMed ID: 21128758
[TBL] [Abstract][Full Text] [Related]
13. Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen.
Magagnoli M; Masci G; Carnaghi C; Zucali PA; Castagna L; Morenghi E; Santoro A
Ann Oncol; 2003 Jun; 14(6):959-60. PubMed ID: 12796035
[No Abstract] [Full Text] [Related]
14. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.
Boraks P; Seale J; Price J; Bass G; Ethell M; Keeling D; Mahendra P; Baglin T; Marcus R
Br J Haematol; 1998 Jun; 101(3):483-6. PubMed ID: 9633891
[TBL] [Abstract][Full Text] [Related]
15. Superior venocaval obstruction secondary to central venous catheter-related thromboses in two patients with metastatic colorectal carcinoma receiving weekly 5-flurouracil. Should adjusted-dose warfarin be used as thromboprophylaxis?
Mainwaring CJ; Naylor E; Jerwood S; Hall V; Page A; James CM
Blood Coagul Fibrinolysis; 2002 Dec; 13(8):749-53. PubMed ID: 12441915
[TBL] [Abstract][Full Text] [Related]
16. An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications.
Yood MU; Quesenberry CP; Alford SH; Tsai AL; Wells KE; Yood SM; Ackermann Shiff SP
Curr Med Res Opin; 2006 Feb; 22(2):307-14. PubMed ID: 16466602
[TBL] [Abstract][Full Text] [Related]
17. Warfarin and reduced central venous thrombosis in home total parenteral nutrition patients.
Veerabagu MP; Tuttle-Newhall J; Maliakkal R; Champagne C; Mascioli EA
Nutrition; 1995; 11(2):142-4. PubMed ID: 7647477
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer.
Howell JD; Warren HW; Anderson JH; Kerr DJ; McArdle CS
Eur J Surg; 1999 Jul; 165(7):652-8. PubMed ID: 10452259
[TBL] [Abstract][Full Text] [Related]
19. Possible drug interaction between warfarin and combination of levamisole and fluorouracil.
Scarfe MA; Israel MK
Ann Pharmacother; 1994 Apr; 28(4):464-7. PubMed ID: 8038468
[TBL] [Abstract][Full Text] [Related]
20. Changes in Pharmacodynamic Parameters during Co-administration of 5-FU with Warfarin: A Retrospective Case Series.
Tayag JCS; Ishii T; Kokuba S; Hirata T; Shiohira H; Nakamura K
Biol Pharm Bull; 2022; 45(8):1101-1105. PubMed ID: 35908892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
